30, 2017 /CNW/ – Following the November 28, 2017 CanniMed Therapeutics Inc. (“CanniMed”) (TSX: CMED) announcement that it has unilaterally adopted a shareholders' rights plan (the “Poison Pill”) in response to the compelling offer (the “Offer”) made by Aurora Cannabis Inc. (the “Company” or ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment